Oryzon Genomics SA

📍 Cornellà de Llobregat, Spain🗓 Founded 2000👥 57 employees💰 Last funded 2007
Biotechnology🌐 oryzon.com
Website LinkedIn
Oryzon Genomics, S.A. is a clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics, with a strong focus on personalized medicine approaches to CNS disorders and oncology. Oryzon has a broad and growing portfolio, with two compounds in clinical trials: iadademstat, a highly potent and selective LSD1 inhibitor, in Phase IIa clinical trials for the treatment of acute myeloid leukemia and small cell lung cancer, and vafidemstat, a CNS optimized LSD1 inhibitor in multiple Phase II trials for the treatment of CNS and psychiatric diseases. Phase IIb trials for both compounds are under preparation. Our pipeline also includes ORY-3001, a selective LSD1 inhibitor in preclinical development for the treatment of non-oncological diseases, and additional programs for developing inhibitors against other epigenetic targets. Oryzon has a strong technological platform for biomarker identification and performs biomarker and target validation for a variety of malignant and neurological diseases. Oryzon has been listed on the Spanish Stock Exchange since December 2015 (ORY, ISIN Code: ES0167733015). Since then, the company has attracted specialized investors from US, Israel and Europe in several PIPEs led by different US investment banks. The company was founded in 2000 and has offices in Spain and the United States.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2000
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Luxembourg
1
Frequently asked questions
Who invested in Oryzon Genomics SA?
Oryzon Genomics SA has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Oryzon Genomics SA last raise funding?
The most recent investment in Oryzon Genomics SA recorded on gritt.io was in 2007.
When was Oryzon Genomics SA founded?
Oryzon Genomics SA was founded in 2000.
What industry is Oryzon Genomics SA in?
Oryzon Genomics SA operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Oryzon Genomics SA based?
Oryzon Genomics SA is headquartered in Cornellà de Llobregat, Spain.